Harnessing the Power of Nutrients β’ 818 implied HN points β’ 22 Nov 22
- A new study highlights the concern that nicotinamide riboside (NR) could potentially fuel cancer growth, especially in the case of triple-negative breast cancer.
- The study utilized mice models to show that NR supplementation could lead to increased tumor prevalence and metastasis in triple-negative breast cancer cells.
- The research suggests that the strategies for preventing cancer differ from those required for treating cancer, emphasizing the importance of nourishing detoxification and immune surveillance.